97 related articles for article (PubMed ID: 11363927)
1. Drug combo safe for HIV-infected children.
NIAID AIDS Agenda; 1996 Sep; ():7. PubMed ID: 11363927
[TBL] [Abstract][Full Text] [Related]
2. Combination therapy with stavudine and didanosine in children with advanced human immunodeficiency virus infection: pharmacokinetic properties, safety, and immunologic and virologic effects.
Kline MW; Fletcher CV; Federici ME; Harris AT; Evans KD; Rutkiewicz VL; Shearer WT; Dunkle LM
Pediatrics; 1996 Jun; 97(6 Pt 1):886-90. PubMed ID: 8657531
[TBL] [Abstract][Full Text] [Related]
3. The safety profile and antiviral activity of the combination of stavudine, didanosine, and nelfinavir in patients with HIV infection.
Elion R; Kaul S; Knupp C; Adler M; Cross AP; Dunkle LM; Kelleher T
Clin Ther; 1999 Nov; 21(11):1853-63. PubMed ID: 10890257
[TBL] [Abstract][Full Text] [Related]
4. Combination therapy with stavudine (d4T) plus didanosine (ddI) in children with human immunodeficiency virus infection. The Pediatric AIDS Clinical Trials Group 327 Team.
Kline MW; Van Dyke RB; Lindsey JC; Gwynne M; Culnane M; Diaz C; Yogev R; McKinney RE; Abrams EJ; Mofenson LM
Pediatrics; 1999 May; 103(5):e62. PubMed ID: 10224206
[TBL] [Abstract][Full Text] [Related]
5. ddI plus d4T.
James JS
AIDS Treat News; 1996 Sep; (No 254):4. PubMed ID: 11363818
[TBL] [Abstract][Full Text] [Related]
6. d4T and ddI shown to be safe and effective.
AIDS Patient Care STDS; 1997 Aug; 11(4):287. PubMed ID: 11361844
[No Abstract] [Full Text] [Related]
7. What we know about anti-HIV drugs.
Treat Rev; 1995 May; (no 18):3-4. PubMed ID: 11362592
[TBL] [Abstract][Full Text] [Related]
8. Safety and antiretroviral effects of combined didanosine and stavudine therapy in HIV-infected individuals with CD4 counts of 200 to 500 cells/mm3.
Pollard RB; Peterson D; Hardy D; Pottage J; Murphy RL; Gathe J; Beall G; Rutkievicz V; Reynolds L; Cross AP; Dunkle LM
J Acquir Immune Defic Syndr; 1999 Sep; 22(1):39-48. PubMed ID: 10534145
[TBL] [Abstract][Full Text] [Related]
9. Didanosine plus stavudine with or without hydroxyurea in HIV-1-infected patients: 1 year follow-up. Swiss HIV Cohort Study.
Rutschmann OT; Opravil M; Iten A; Malinverni R; Vernazza PL; Bucher H; Bernasconi E; Perrin LH; Yerly S; Hirschel B
Antivir Ther; 1998; 3 Suppl 4():65-7. PubMed ID: 10723515
[TBL] [Abstract][Full Text] [Related]
10. [Antiretroviral therapy. Current status and perspectives].
Lüthy R
Internist (Berl); 1994 Oct; 35(10):896-900. PubMed ID: 8002223
[No Abstract] [Full Text] [Related]
11. Efficacy and safety of stavudine plus didanosine in asymptomatic HIV-infected children with plasma HIV RNA below 50,000 copies per milliliter.
de Mendoza C; Ramos JT; Ciria L; Fortuny C; García FJ; de José MI; Asensi F; Soriano V
HIV Clin Trials; 2002; 3(1):9-16. PubMed ID: 11819180
[TBL] [Abstract][Full Text] [Related]
12. d4T plus ddI antiviral results.
AIDS Treat News; 1996 Feb; (no 241):3. PubMed ID: 11363187
[TBL] [Abstract][Full Text] [Related]
13. In vivo antagonism with zidovudine plus stavudine combination therapy.
Havlir DV; Tierney C; Friedland GH; Pollard RB; Smeaton L; Sommadossi JP; Fox L; Kessler H; Fife KH; Richman DD
J Infect Dis; 2000 Jul; 182(1):321-5. PubMed ID: 10882616
[TBL] [Abstract][Full Text] [Related]
14. Antiretroviral drug resistance.
Japour AJ
AIDS Clin Care; 1995 Aug; 7(8):63-5, 67. PubMed ID: 11362787
[TBL] [Abstract][Full Text] [Related]
15. Combining d4T/ddI looks promising.
Posit Aware; 1996; 7(1):7. PubMed ID: 11363129
[TBL] [Abstract][Full Text] [Related]
16. A randomized trial to investigate the recycling of stavudine and didanosine with and without hydroxyurea in salvage therapy (RESTART).
Stebbing J; Nelson M; Orkin C; Mandalia S; Bower M; Pozniak A; Gazzard B
J Antimicrob Chemother; 2004 Mar; 53(3):501-5. PubMed ID: 14762056
[TBL] [Abstract][Full Text] [Related]
17. Mutations conferring resistance to zidovudine diminish the antiviral effect of stavudine plus didanosine.
Izopet J; Bicart-See A; Pasquier C; Sandres K; Bonnet E; Marchou B; Puel J; Massip P
J Med Virol; 1999 Dec; 59(4):507-11. PubMed ID: 10534734
[TBL] [Abstract][Full Text] [Related]
18. Nevirapine triple combo results released.
Common Factor; 1995 Apr; (no 10):21. PubMed ID: 11362346
[TBL] [Abstract][Full Text] [Related]
19. ddI + d4T + IDV well tolerated in HIV-infected children.
AIDS Patient Care STDS; 1997 Oct; 11(5):373. PubMed ID: 11361822
[No Abstract] [Full Text] [Related]
20. Kinetics of tumor necrosis factor alpha and soluble TNFRII in HIV-infected patients treated with a triple combination of stavudine, didanosine, and hydroxyurea.
Nokta M; Rossero R; Loesch K; Pollard RB
AIDS Res Hum Retroviruses; 1997 Dec; 13(18):1633-8. PubMed ID: 9430255
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
